Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma.

作者信息

Leavitt R D, Ratanatharathorn V, Ozer H, Ultmann J E, Portlock C, Myers J W, Kisner D, Norred S, Spiegel R J, Bonnem E M

出版信息

Semin Oncol. 1987 Jun;14(2 Suppl 2):18-23.

PMID:3589702

Abstract

摘要

相似文献

Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma.

Semin Oncol. 1987 Jun;14(2 Suppl 2):18-23.

Advances in the management of Hodgkin's and non-Hodgkin's lymphoma.霍奇金淋巴瘤和非霍奇金淋巴瘤的管理进展

Curr Opin Hematol. 1998 Jul;5(4):259-63. doi: 10.1097/00062752-199807000-00005.

The role of interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma.干扰素α-2b与苯丁酸氮芥在非霍奇金淋巴瘤治疗中的作用。

Cancer Treat Rev. 1988 Jan;15 Suppl A:27-33. doi: 10.1016/0305-7372(88)90071-0.

Chlorambucil and interferon for low grade non-Hodgkin's lymphoma.苯丁酸氮芥与干扰素治疗低度非霍奇金淋巴瘤

Br J Cancer. 1987 Feb;55(2):225-6. doi: 10.1038/bjc.1987.42.

Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's disease.环磷酰胺、卡铂和依托泊苷联合自体造血干细胞移植并在移植后使用α-2b干扰素治疗淋巴瘤和霍奇金病患者的I/II期研究。

J Clin Oncol. 1994 Nov;12(11):2423-31. doi: 10.1200/JCO.1994.12.11.2423.

Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society trial.人α干扰素治疗恶性淋巴瘤和霍奇金病。美国癌症协会试验结果。

Cancer. 1985 Sep 15;56(6):1305-10. doi: 10.1002/1097-0142(19850915)56:6<1305::aid-cncr2820560614>3.0.co;2-n.

Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma.低剂量与高剂量干扰素α-2a治疗复发惰性非霍奇金淋巴瘤的疗效比较

J Natl Cancer Inst. 1990 Feb 7;82(3):235-8. doi: 10.1093/jnci/82.3.235.

Interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma.干扰素α-2b与苯丁酸氮芥治疗非霍奇金淋巴瘤

Invest New Drugs. 1987;5 Suppl:S35-40. doi: 10.1007/BF00207261.

Interferon therapy of non-Hodgkin's lymphoma.非霍奇金淋巴瘤的干扰素治疗

Cancer. 1987 Feb 1;59(3 Suppl):601-4. doi: 10.1002/1097-0142(19870201)59:3+<601::aid-cncr2820591304>3.0.co;2-j.

Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.干扰素α联合细胞毒性化疗用于非霍奇金淋巴瘤患者

N Engl J Med. 1992 Nov 5;327(19):1336-41. doi: 10.1056/NEJM199211053271902.

引用本文的文献

A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma.一项评估干扰素作为滤泡性淋巴瘤患者初始及维持治疗作用的随机对照试验。

Br J Cancer. 2001 Jul 6;85(1):29-35. doi: 10.1054/bjoc.2001.1822.

The role of interferon as maintenance therapy in malignant lymphoma.干扰素在恶性淋巴瘤维持治疗中的作用。

Med Oncol. 1997 Sep-Dec;14(3-4):153-7. doi: 10.1007/BF02989643.

Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA.用干扰素α-2a联合阿维A或补骨脂素紫外线A光化学疗法（PUVA）治疗低度皮肤T细胞淋巴瘤期间抗干扰素抗体的发生率及体内相关性

Arch Dermatol Res. 1996 Aug;288(9):543-8. doi: 10.1007/BF02505252.

Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b.接受α-2b干扰素维持治疗的多发性骨髓瘤患者中的中和抗体

Br J Cancer. 1994 Oct;70(4):646-51. doi: 10.1038/bjc.1994.365.

Interferon-alpha in malignant and viral diseases. A review.α干扰素在恶性疾病和病毒性疾病中的应用。综述

Drugs. 1993 Feb;45(2):177-211. doi: 10.2165/00003495-199345020-00003.

The management of follicular lymphoma.滤泡性淋巴瘤的管理

Drugs. 1994;47 Suppl 6:10-8. doi: 10.2165/00003495-199400476-00004.

The role of interferons in the treatment of malignant neoplasms.干扰素在恶性肿瘤治疗中的作用。

Yale J Biol Med. 1989 May-Jun;62(3):271-90.

Malignant lymphomas in HIV-seropositive patients. Frequency, features, and prognosis. Report on 31 cases.

Klin Wochenschr. 1991 Oct 2;69(15):679-86. doi: 10.1007/BF01649436.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验